PRA Health Sciences, Inc. (NASDAQ:PRAH) management will conduct a conference call for 7th August 2020 at 9:00 AM Eastern Time to discuss financial results and companys performance for 2Q20.
The company released its quarterly earnings, after the market close on Thursday 6th August 2020
The conference call will also be available live on the website prahs.com
Quarterly Results
PRA Health Sciences, Inc. announced income for the second quarter of $ 0.86 per share, from the revenue of $ 729.89 million. The quarterly earnings shrunk 29.51 percent while revenues dropped 4.38 percent compared with the same quarter last year.
Wall street analysts are predicting, PRAH to report 2Q20 income of $ 0.83 per share from revenue of $ 716.72 million. The bottom line results beat street analysts by $ 0.03 or 3.61 percent, at the same time, top line results outshined analysts by $ 13.17 million or 1.84 percent.
PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services.
